Targeting the transcriptional machinery with unique artificial transcriptional activators

Journal of the American Chemical Society

Volumn 125, Issue 41, 2003, Pages 12390-12391

  Wu, Zhiqian ^a   Belanger, Garrette ^a   Brennan, Brian B ^a   Lum, Jenifer K ^a   Minter, Aaron R ^a   Rowe, Steven P ^a   Plachetka, Annette ^a   Majmudar, Chinmay Y ^a   Mapp, Anna K ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; DNA; HYBRID PROTEIN; LIGAND; NUCLEIC ACID; OLIGONUCLEOTIDE; PEPTIDE; PEPTIDE LIBRARY; POLYAMIDE; REGULATOR PROTEIN; RNA POLYMERASE II; TRANSCRIPTIONAL ACTIVATOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CHROMATIN STRUCTURE; DNA BINDING; ENZYME REGULATION; GENE EXPRESSION REGULATION; GENE TARGETING; MOLECULAR RECOGNITION; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; TECHNIQUE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; SACCHAROMYCES CEREVISIAE PROTEINS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0141988965     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja036685v     Document Type: Article

References (28)

1. Ptashne, M.; Gann, A. Genes & Signals; Cold Spring Harbor Laboratory: New York, 2001.
2. (a) Pandolfi, P. P. Oncogene 2001, 20, 3116-3127.
3. (b) Perou, C. M.; Sorlie, T.; Eisen, M. B.; van de Rijn, M.; Jeffrey, S. S.; Rees, C. A.; Pollack, J. R.; Ross, D. T.; Johnsen, H.; Aksien, L. A.; Fluge, O.; Pergamenschikov, A.; Williams, C.; Zhu, S. X.; Lonning, P. E.; Borresen-Dale, A. L.; Brown, P. O.; Botstein, D. Nature 2000, 406, 747-752.
4. Ansari, A. Z.; Mapp, A. K. Curr. Opin. Chem. Biol. 2002, 6, 765-772.
5. (a) Beerli, R. R.; Barbas, C. F. Nat. Biotechnol. 2002, 20, 135-141.
6. (b) Faria, M.; Giovannangeli, C. J. Gene. Med. 2001, 3, 299-310.
7. (c) Dervan, P. B. Bioorg. Med. Chem. 2001, 9, 2215-2235.
8. (a) Han, Y.; Kodadek, T. J. Biol. Chem. 2000, 275, 14979-14984.
9. (b) Ma, J.; Ptashne, M. Cell 1987, 51, 113-119.
10. (c) Giniger, E.; Ptashne, M. Nature 1987, 330, 670-672.
11. (d) Mapp, A. K.; Ansari, A. Z.; Ptashne, M.; Dervan, P. B. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 3930-3935.
12. (e) Frangioni, J. V.; LaRiccia, L. M.; Cantley, L. C.; Montminy, M. R. Nat. Biotechnol. 2000, 18, 1080-1085.
13. For an exception, see: (a) Lu, X. Y.; Ansari, A. Z.; Ptashne, M. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 1988-1992.
14. (b) Lu, Z.; Ansari, A. Z.; Lu, X. Y.; Ogirala, A.; Ptashne, M. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 8591-8596.
15. Myers, L. C.; Kornberg, R. D. Annu. Rev. Biochem. 2000, 69, 729-749.
16. Dotson, M. R.; Yuan, C. X.; Roeder, R. G.; Myers, L. C.; Gustafsson, C. M.; Jiang, Y. W.; Li, Y.; Kornberg, R. D.; Asturias, F. J. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 14307-14310.
17. (a) Park, J. M.; Kim, H. S.; Han, S. J.; Hwang, M. S.; Lee, Y. C.; Kim, Y. J. Mol. Cell. Biol. 2000, 20, 8709-8719.
18. (b) Jeong, C. J.; Yang, S. H.; Xie, Y. Q.; Zhang, L.; Johnston, S. A.; Kodadek, T. Biochemistry 2001, 40, 9421-9427.
19. (c) Koh, S. S.; Ansari, A. Z.; Ptashne, M.; Young, R. A. Mol. Cell 1998, 1, 895-904.
20. Barberis, A.; Pearlberg, J.; Simkovich, N.; Farrell, S.; Reinagel, P.; Bamdad, C.; Sigal, G.; Ptashne, M. Cell 1995, 81, 359-368.
21. Tanaka, M. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 4311-4315.
22. Zaman, Z.; Ansari, A. Z.; Koh, S. S.; Young, R.; Ptashne, M. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 2550-2554.
23. Burke, D.; Dawson, D.; Steams, T. Methods in Yeast Genetics, 1st ed.; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NJ, 2000.
24. (a) Wu, Y. B.; Reece, R. J.; Ptashne, M. EMBO J. 1996, 15, 3951-3963.
25. (b) Melcher, K. J. Mol. Biol. 2000, 301, 1097-1112 and references therein.
26. Lakowicz, J. R. Principles of Flourescence Spectrocopy; Plenum Press: New York and London, 1999.
27. In the case of two ADs that target the same binding site, the affinity of each AD for that site would presumably strongly affect functional potency.
28. An alternate approach for developing nonbiopolymer-based ADs is to identify molecules that inhibit activator-target protein interactions. One such inhibitor was recently reported, although its function as an AD has not yet been described: Asada, S.; Choi, Y.; Uesugi, M. J. Am. Chem. Soc. 2003, 125, 4992-4993.